🔄 Metabolic

メタボリックシンドローム:リスク因子群

メタボリックシンドロームは、一緒に発生する状態のグループで、心臓病、脳卒中、2型糖尿病のリスクを大幅に高めます。

Prevalence:~34% of U.S. adults

メタボリックシンドロームとは?

5つのリスク因子のうち少なくとも3つを持っている場合にメタボリックシンドロームと診断されます:腹部肥満、高トリグリセリド、低HDLコレステロール、高血圧、空腹時血糖上昇。

5つの診断基準

1) 腹囲>85cm(男性)または>90cm(女性、日本基準)。2) トリグリセリド≥150 mg/dL。3) HDL<40 mg/dL(男性)または<50 mg/dL(女性)。4) 血圧≥130/85 mmHg。5) 空腹時血糖≥100 mg/dL。

健康リスク

メタボリックシンドロームは2型糖尿病と心血管疾患のリスクを大幅に高めます。

生活習慣による改善

メタボリックシンドロームは生活習慣の変更によって改善できることが多い:減量、定期的な運動、健康的な食事。

🌍 Regional Context

メタボリックシンドロームの有病率は肥満率の上昇とともに世界的に増加しています。

日本では成人の約20%がメタボリックシンドロームを持っています。「メタボ健診」として知られる特定健康診査が40歳以上に義務化されています。

データ出典:日本内科学会、厚生労働省。

❓ Frequently Asked Questions

診断にはいくつの基準が必要ですか?

メタボリックシンドロームと診断されるには、5つの基準のうち少なくとも3つを満たす必要があります。

📊 監視すべき主要指標

これらの健康指標はmetabolic syndromeの診断とモニタリングに不可欠です:

🔬 Diagnostic Criteria

Healthcare providers use these thresholds to diagnose and classify metabolic syndrome:

MetricThresholdClassification
Waist>40" (men), >35" (women)Criterion 1
Triglycerides≥150 mg/dLCriterion 2
HDL<40 (men), <50 (women) mg/dLCriterion 3
Blood Pressure≥130/85 mmHgCriterion 4
Fasting Glucose≥100 mg/dLCriterion 5

Note: Diagnosis requires clinical evaluation. These criteria are for reference only.

⚠️ Risk Factors

Abdominal obesity
Insulin resistance
Physical inactivity
Aging
Genetics
Hormonal imbalances

🔴 Potential Complications

If left unmanaged, metabolic syndrome may lead to:

Type 2 diabetes
Heart disease
Stroke
Non-alcoholic fatty liver disease

✅ Prevention Strategies

1Regular physical activity
2Heart-healthy diet
3Maintain healthy waist circumference
4Control blood pressure
5Manage cholesterol levels

🧬 Understanding Metabolic Syndrome

Medical Literature

Metabolic syndrome represents the clustering of insulin resistance, central obesity, dyslipidemia, and hypertension. Visceral adipose tissue releases inflammatory adipokines (TNF-α, IL-6) and free fatty acids, driving insulin resistance. Insulin resistance increases hepatic VLDL production (elevated triglycerides) and reduces HDL. Compensatory hyperinsulinemia promotes sodium retention (hypertension) and vascular dysfunction. The syndrome amplifies cardiovascular risk beyond individual components—it represents a pro-inflammatory, pro-thrombotic state.

📈 Epidemiology & Statistics

CDC / WHO Data
Global Prevalence
Affects approximately 25% of adults worldwide
U.S. Prevalence
34.2% of U.S. adults meet criteria (NHANES)
Trend
Increasing with obesity epidemic
Demographics
Increases with age, higher in Hispanic adults
Data from CDC National Health Statistics, WHO Global Health Observatory, and peer-reviewed epidemiological studies.

🔍 Screening Recommendations

AHA/NHLBI
Recommended Frequency: During routine cardiovascular risk assessment

Recommended Tests

  • Waist circumference measurement
  • Fasting glucose or HbA1c
  • Lipid panel (triglycerides, HDL)
  • Blood pressure
💡 Note: Screening recommendations may vary based on individual risk factors. Consult with your healthcare provider for personalized screening guidance.

💊 Treatment Approaches

Clinical Guidelines

Weight Loss

1

7-10% weight loss addresses multiple components

Effectiveness: Improves all metabolic parameters

Physical Activity

2

150+ min/week moderate intensity

Effectiveness: Improves insulin sensitivity independent of weight loss

Diet Modification

3

Mediterranean or DASH diet patterns

Effectiveness: Reduces inflammation and improves lipids

Targeted Medications

4

Treat individual components as needed

Effectiveness: Reduce cardiovascular events
⚠️ Medical Disclaimer: Treatment decisions should be made with healthcare providers based on individual circumstances, preferences, and the latest clinical evidence.

🔬 Recent Research & Advances

Peer-Reviewed Studies
📄Lifestyle intervention more effective than medication in prevention
📄Gut microbiome composition linked to metabolic syndrome
📄Time-restricted eating shows metabolic benefits
📄Debate continues on whether syndrome is distinct from sum of parts
Research in this field is rapidly evolving. These highlights represent recent developments from major clinical trials and peer-reviewed publications.

📊 Understanding Related Metrics

These health metrics play key roles in diagnosing, monitoring, and managing metabolic syndrome. Understanding what each measures helps you better interpret your results.

Waist Circumference

Role: Central obesity measure

View benchmarks →

Triglycerides

Role: Blood fat level

View benchmarks →

HDL Cholesterol

Role: Good cholesterol

View benchmarks →

Blood Pressure

Role: Cardiovascular indicator

View benchmarks →

Fasting Glucose

Role: Blood sugar level

View benchmarks →

❓ Frequently Asked Questions

What is Metabolic Syndrome?

Metabolic syndrome represents the clustering of insulin resistance, central obesity, dyslipidemia, and hypertension. Visceral adipose tissue releases inflammatory adipokines (TNF-α, IL-6) and free fatty acids, driving insulin resistance. Insulin resistance increases hepatic VLDL produc...

How common is Metabolic Syndrome?

34.2% of U.S. adults meet criteria (NHANES)

What metrics should I monitor for Metabolic Syndrome?

Key metrics include: Waist Circumference, Triglycerides, HDL Cholesterol, Blood Pressure, Fasting Glucose. Regular monitoring of these values can help track disease status and treatment response.

How is Metabolic Syndrome diagnosed?

Diagnosis typically involves: Waist circumference measurement, Fasting glucose or HbA1c, Lipid panel (triglycerides, HDL). Your healthcare provider will interpret these results in the context of your overall health.

Can Metabolic Syndrome be prevented?

Prevention strategies typically focus on lifestyle modifications and managing risk factors. Early detection through screening is also important.

🔗 関連する疾患

あなたの指標を探索

インタラクティブな計算機を使って、人口ベンチマークと自分の値を比較してください。

📊Data Transparency & Sources